Healthcare - Medical - Instruments & Supplies - NYSE - US
$ 20.57
2.44 %
$ 3.54 B
Market Cap
-2.66
P/E
INCOME STATEMENT
2.57 B
REVENUE
31.5 M
OPERATING INCOME
-100 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Envista Holdings Corporation
| Revenue | 2.57 B |
| Cost Of Revenue | 1.12 B |
| Gross Profit | 1.45 B |
| Operating Expenses | 1.15 B |
| Operating Income | 31.5 M |
| Other Expenses | 132 M |
| Net Income | -100 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Revenue | 2 566.5 | 2 569.1 | 2 508.9 | 2 282.0 | 2 751.6 | 2 844.5 | 2 810.9 | 2 785.4 |
| GROSS PROFIT | ||||||||
| Cost Of Revenue | 1 116.0 | 1 094.3 | 1 082.4 | 1 123.9 | 1 238.5 | 1 242.7 | 1 189.7 | 1 184.3 |
| Gross Profit | 1 450.5 | 1 474.8 | 1 426.5 | 1 158.1 | 1 513.1 | 1 601.8 | 1 621.2 | 1 601.1 |
| OPERATING INCOME | ||||||||
| Operating Expenses | 1 150.7 | 1 155.6 | 1 120.3 | 1 124.8 | 1 235.6 | 1 303.4 | 1 234.6 | 1 198.3 |
| Selling, General and Administrative Expenses | 1 056.9 | 1 055.5 | 1 019.8 | 1 024.0 | 1 080.9 | 1 131.4 | 1 062.2 | 1 055.5 |
| Research and Development Expenses | 93.8 | 100.1 | 100.5 | 100.8 | 154.7 | 172.0 | 172.4 | 142.8 |
| Operating Income | 31.5 | 319.2 | 306.2 | 33.3 | 110.9 | 298.4 | 386.6 | 402.8 |
| PRE-TAX INCOME | ||||||||
| Interest Income Expense | 63.4 | 38.4 | 54.1 | 62.5 | 3.5 | 0 | 0 | 0 |
| Total Other Income | (86.4) | (35.3) | (51.7) | (63.5) | 39.8 | 2.7 | 100 K | (1.1) |
| Pre-Tax Income | (54.9) | 283.9 | 254.5 | (30.1) | 275.5 | 301.1 | 386.7 | 401.7 |
| NET INCOME | ||||||||
| Tax Provision | 45.3 | 45.9 | (9.0) | (63.4) | 57.9 | 70.4 | 85.6 | 129.7 |
| Net Income | (100.2) | 243.1 | 263.5 | 33.3 | 217.6 | 230.7 | 301.1 | 272.0 |
| EPS | 0.6 | 1.46 | 1.63 | 0.21 | 1.6 | 1.49 | 1.95 | 1.76 |